Custom Synthesis

Alflutinib Mesylate View larger

Alflutinib Mesylate

AOB16487

CAS 2130958-55-1

More details

Molarity Calculation Cart®

HOW TO ORDER

$0.00

More info

Novel third-generation irreversible EGFR TKI for the treatment of non-small cell lung cancer (NSCLC) with EGFR-sensitizing and T790M resistance mutations